Loading...
anti-inflammatory→choroidal vascular protection
Statins may protect against age-related macular degeneration through anti-inflammatory effects, reduction of oxidative stress, and improvement of choroidal blood flow. Multiple papers including epidemiological studies and a systematic review support this association, though the support ratio in co-mention analysis is 0% suggesting many neutral mentions. Evidence remains observational/exploratory rather than from definitive RCTs.
“Effect of statins on the age of onset of age-related macular degeneration.”
— Effect of statins on the age of onset of age-related macular degeneration. (2023)DOI“Statins and the progression of age-related macular degeneration in the United States.”
— Statins and the progression of age-related macular degeneration in the United States. (2021)DOI“Statins, widely prescribed for cardiovascular diseases, are also being eyed for management of age-related macular degeneration (AMD).”
— Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD). (2020)DOI“Impact of long-term statin therapy on age-related macular degeneration: A nationwide population-based study.”
— Impact of long-term statin therapy on age-related macular degeneration: A nationwide population-based study. (2025)DOI“Statins for age related macular degeneration: promising but unproven”
— Statins for age related macular degeneration: promising but unproven (2021)DOI